Artificial T-cell receptors provide enhanced ability to T-cells for targeting a specific protein. These receptors are often called as Chimeric Antigen Receptor (CAR) or Chimeric T-Cell Receptor which are bound to surface of T-cells and serve the purpose of alerting immune systems about the impending virus attack. The artificial T-cell receptors market is expected to grow at an impressive growth rate over the forecast period. A major factor that augments the growth of the market is the rising prevalence of cancer disease across the globe. Moreover, increasing incidence of immunological diseases and chronic diseases such as cardiovascular diseases across the globe is further fueling the market growth.
Request a free sample of our report on Global Artificial T-cell Receptors Market: https://www.omrglobal.com/request-sample/artificial-t-cell-receptors-market

Significant prevalence of cancer disease has been observed in the US. According to the American Cancer Society in 2017, it was estimated that out of total 600,920 cancer deaths in the US, around 190,500 would be caused by cigarette smoking. In addition, it was estimated by the World Cancer Research Fund that 20% of cancers are caused by factors such as physical inactivity, excess body weight, excess alcohol consumption, and poor nutrition. Moreover, as per American Cancer Society in 2017, 87% of all the cancers in the US were diagnosed in people with age 50 years and above. However, these cancers were preventable. Additionally, colorectal and cervical cancers can be prevented by screening and by removal of precancerous lesions. Screening also has reduced the mortality rate significantly for the cancers of colon, breast, and lung. These facts and figures reflect the need for less-toxic forms of immune-based cellular therapy such as T-cell receptors therapy to treat cancer which ultimately results in positive market growth.
A full report of Global Artificial T-cell Receptors Market Is available at https://www.omrglobal.com/industry-reports/artificial-t-cell-receptors-market

Global Artificial T-Cell Receptors Market Segmentation
By Disease
Cancer
Acute Lymphoblastic Leukemia (ALL)
Diffuse Large B-Cell Lymphoma
Other Cancer Types
Immunological Disorders
By Therapy
Autologous
Allogenic
By End-User
Research Institutes
Hospitals
Biotech Companies
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles
Adaptive Biotechnologies Corp.
Athenex, Inc.
Blubird Bio, Inc.
Cabaletta Bio, Inc.
Celgene Corp.
Cell Medica Ltd.
Eli Lilly & Co.
Juno Therapeutics, Inc.
Kite Pharma, Inc.
Lonza Group Ltd.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/artificial-t-cell-receptors-market
About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404